All the news Showing 10 of 17 articles from: CoronavirusGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources COVID-19 slows viral hepatitis elimination, global survey finds Keith Alcorn / 22 February 2021 COVID-19 has caused substantial disruption to viral hepatitis screening and treatment, a global survey finds, but has also led to improvements in laboratory capacity and telemedicine that will benefit future efforts to eliminate ... Hepatitis C does not raise the risk of death from COVID-19 Keith Alcorn / 19 February 2021 People with hepatitis C were more likely to be admitted to hospital as a result of SARS-CoV-2 infection but no more likely to die when compared to people without hepatitis C of ... Will people with liver disease be prioritised for COVID-19 vaccination? Keith Alcorn / 19 January 2021 People with decompensated cirrhosis should be prioritised for COVID-19 vaccination and immunosuppressive treatment after a liver transplant should not be a barrier to vaccination, an international panel of liver experts has concluded. Their review ... Fatty liver greatly increases vulnerability to COVID-19 in obese people Keith Alcorn / 16 November 2020 Fatty liver disease combined with obesity places people at much higher risk of severe COVID-19, analysis of British people who tested positive for SARS-CoV-2 shows. Obesity alone did not increase the risk ... Which people with chronic liver disease have higher COVID-19 risks? Keith Alcorn / 16 November 2020 Decompensated cirrhosis, alcoholic liver disease and hepatocellular carcinoma each raise the risk of death and severe illness from COVID-19 among people with chronic liver disease, but other liver conditions do not, a US ... International registries provide more information about COVID-19 and liver disease Liz Highleyman / 17 September 2020 People with advanced liver cirrhosis are more likely to develop severe COVID-19 complications and to die from it, but those who have received liver transplants do not appear to be at greater ... EASL updates guidance on COVID-19 in liver disease patients Keith Alcorn / 11 August 2020 The European Association for the Study of the Liver (EASL) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have updated their guidance on chronic liver disease and COVID-19, issued in ... COVID-19 slows hepatitis elimination Keith Alcorn / 04 August 2020 Hepatitis elimination efforts are being severely affected by the COVID-19 pandemic in many settings, results of a 32-country survey by the World Hepatitis Alliance show. The survey of civil society hepatitis organisations and frontline ... How often does COVID-19 cause liver disorders? Keith Alcorn / 21 July 2020 Increases in liver enzymes are common in people with COVID-19 and occur more frequently in people with severe COVID-19, a meta-analysis of studies published in Hepatology International shows. Most liver enzyme elevations were ... Hepatitis C drugs may offer an inexpensive treatment option for COVID-19 Liz Highleyman / 20 July 2020 Sofosbuvir and daclatasvir, two antiviral drugs used to treat hepatitis C, were associated with faster recovery, shorter hospitalisation and improve survival among people with moderate or severe COVID-19, researchers reported this month at the ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds